Free Trial

SELLAS Life Sciences Group (SLS) News Today

SELLAS Life Sciences Group logo
$1.56 -0.06 (-3.42%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SLS Latest News

Sellas Life Sciences: Tons Of Completed Studies
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Increase in Short Interest
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) saw a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 12,220,000 shares, an increase of 39.5% from the May 15th total of 8,760,000 shares. Based on an average daily volume of 1,910,000 shares, the days-to-cover ratio is presently 6.4 days. Currently, 17.6% of the company's shares are short sold.
SELLAS Life Sciences Group, Inc. stock logo
Nostrand Robert L. Van Acquires 10,000 Shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Stock
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) Director Nostrand Robert L. Van purchased 10,000 shares of SELLAS Life Sciences Group stock in a transaction on Thursday, June 12th. The stock was bought at an average price of $1.48 per share, with a total value of $14,800.00. Following the completion of the acquisition, the director now directly owns 20,400 shares of the company's stock, valued at approximately $30,192. This trade represents a 96.15% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
SELLAS Life Sciences Group, Inc. stock logo
Insider Buying: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Director Purchases 20,000 Shares of Stock
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) Director Jane Wasman purchased 20,000 shares of the business's stock in a transaction on Friday, May 30th. The stock was purchased at an average cost of $1.69 per share, for a total transaction of $33,800.00. Following the completion of the acquisition, the director now directly owns 30,400 shares of the company's stock, valued at approximately $51,376. The trade was a 192.31% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
SELLAS Life Sciences Group, Inc. stock logo
594,919 Shares in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Bought by Brooklyn FI LLC
Brooklyn FI LLC acquired a new position in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 594,919 shares of the company's stock, valued a
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group (SLS) to Release Earnings on Tuesday
SELLAS Life Sciences Group (NASDAQ:SLS) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-sellas-life-sciences-group-inc-stock/)
SELLAS Life Sciences Group, Inc. stock logo
Anson Funds Management LP Has $1.24 Million Holdings in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)
Anson Funds Management LP grew its holdings in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Free Report) by 50.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,192,266 shares of the company's stock after purc
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group (NASDAQ:SLS) Trading 1.6% Higher - Time to Buy?
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 1.6% - Time to Buy?
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group (NASDAQ:SLS) Issues Quarterly Earnings Results
SELLAS Life Sciences Group (NASDAQ:SLS - Get Free Report) posted its earnings results on Thursday. The company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.03.
SELLAS Life Sciences Group, Inc. stock logo
Brooklyn FI LLC Takes Position in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)
Brooklyn FI LLC bought a new position in shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 594,919 shares of the company's stock
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group (SLS) to Release Earnings on Thursday
SELLAS Life Sciences Group (NASDAQ:SLS) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports.
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Decrease in Short Interest
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 8,650,000 shares, a decline of 11.8% from the January 31st total of 9,810,000 shares. Based on an average daily volume of 2,700,000 shares, the days-to-cover ratio is currently 3.2 days.
Sellas Life Sciences’ zanubrutinib combination shows efficacy in DLBCL
SELLAS Life Sciences Group, Inc. stock logo
Investors Buy High Volume of Call Options on SELLAS Life Sciences Group (NASDAQ:SLS)
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) was the target of unusually large options trading on Monday. Stock investors purchased 9,455 call options on the company. This represents an increase of 146% compared to the typical daily volume of 3,838 call options.
SELLAS Life Sciences Group, Inc. stock logo
SELLAS Life Sciences Group Sees Unusually High Options Volume (NASDAQ:SLS)
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS - Get Free Report) saw some unusual options trading on Monday. Traders acquired 9,455 call options on the stock. This is an increase of approximately 146% compared to the average volume of 3,838 call options.
SELLAS Announces Key Business Objectives for 2025
Get SELLAS Life Sciences Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.

SLS Media Mentions By Week

SLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLS
News Sentiment

1.27

0.90

Average
Medical
News Sentiment

SLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLS Articles
This Week

7

1

SLS Articles
Average Week

Get SELLAS Life Sciences Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SLS) was last updated on 6/17/2025 by MarketBeat.com Staff
From Our Partners